Cargando…
Diabetes, obesity and COVID‐19: A complex interplay
With the accumulation of observational data showing an association of metabolic co‐morbidities with adverse outcomes from COVID‐19, there is a need to disentangle the contributions of pre‐existing macro‐ and microvascular disease, obesity and glycaemia. This article outlines the complex mechanistic...
Autores principales: | Vas, Prashanth, Hopkins, David, Feher, Michael, Rubino, Francesco, B. Whyte, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362013/ https://www.ncbi.nlm.nih.gov/pubmed/32627299 http://dx.doi.org/10.1111/dom.14134 |
Ejemplares similares
-
The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19
por: Whyte, Martin B., et al.
Publicado: (2020) -
Microvascular disease in diabetes and severe COVID-19 outcomes
por: Corcillo, Antonella, et al.
Publicado: (2021) -
What is the impact of microvascular complications of diabetes on severe COVID-19?
por: Basra, Ruman, et al.
Publicado: (2022) -
Real-World Outcomes for ECMO in COVID-19
por: Nurok, Michael, et al.
Publicado: (2022) -
Sexual dysfunction and prostate cancer risk: one more piece of a complex puzzle
por: Capogrosso, Paolo, et al.
Publicado: (2017)